Application of ventricular tachyarrhythmia definitions of the updated Lambeth Conventions provides incompatibility with earlier results, masks antifibrillatory activity and reduces inter-observer agreement.

The Lambeth Conventions (LC I), a landmark guidance document for arrhythmia research was updated and arrhythmia definitions were changed in the new Lambeth Conventions II (LC II). This study examined whether the arrhythmia definitions of LC I and LC II yield the same qualitative results and whether...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Regev A.
Takács Hedvig
Farkas Attila
Rárosi Ferenc
Polyák Alexandra Júlia
Papp Henrietta
Iványi Emese
Papp Julius Gy
Varró András
Farkas András
Dokumentumtípus: Cikk
Megjelent: 2019
Sorozat:JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 70 No. 1
doi:10.26402/jpp.2019.1.03

mtmt:30703098
Online Access:http://publicatio.bibl.u-szeged.hu/16883
LEADER 03033nab a2200313 i 4500
001 publ16883
005 20230405093901.0
008 191001s2019 hu o 0|| zxx d
022 |a 0867-5910 
024 7 |a 10.26402/jpp.2019.1.03  |2 doi 
024 7 |a 30703098  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Regev A. 
245 1 0 |a Application of ventricular tachyarrhythmia definitions of the updated Lambeth Conventions provides incompatibility with earlier results, masks antifibrillatory activity and reduces inter-observer agreement.  |h [elektronikus dokumentum] /  |c  Regev A. 
260 |c 2019 
300 |a 37-49 
490 0 |a JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY  |v 70 No. 1 
520 3 |a The Lambeth Conventions (LC I), a landmark guidance document for arrhythmia research was updated and arrhythmia definitions were changed in the new Lambeth Conventions II (LC II). This study examined whether the arrhythmia definitions of LC I and LC II yield the same qualitative results and whether LC II improves inter-observer agreement. Two independent investigators performed blinded arrhythmia analysis of the electrocardiograms of isolated, Langendorff rat hearts subjected to regional ischemia and perfused with Class I antiarrhythmics with 3 or 5 mM K+ in the perfusate. Data obtained with arrhythmia definitions of LC I and LC II were compared within and between observers. Applying ventricular fibrillation (VF) definition of LC II significantly increased VF incidence and reduced VF onset time irrespective of treatment by detecting 'de novo' VF episodes not found by LC I. LC II reduced the number of ventricular tachycardia (VT) episodes and simultaneously increased the number of VF episodes as compared with the respective values obtained according to LC I. Using VF definition of LC II masked the significant antifibrillatory effects of flecainide and the high K+ concentration identified with the VF definition of LC I. When VF incidence was tested, a very strong inter-observer agreement was found according to LC I, whereas using VF definition of LC II reduced inter-observer agreement. It is concluded that LC II shifts some tachyarrhythmias from VT to VF class, and thus results obtained by arrhythmia definitions of LC I and LC II are not compatible; VF definition of LC II may change the conclusion of pharmacological, physiological and pathophysiological arrhythmia investigations and may reduce inter-observer agreement. Thus, VT and VF definitions of LC II should be amended in order to increase compatibility and inter-observer agreement. 
700 0 1 |a Takács Hedvig  |e aut 
700 0 1 |a Farkas Attila  |e aut 
700 0 1 |a Rárosi Ferenc  |e aut 
700 0 1 |a Polyák Alexandra Júlia  |e aut 
700 0 1 |a Papp Henrietta  |e aut 
700 0 1 |a Iványi Emese  |e aut 
700 0 1 |a Papp Julius Gy.  |e aut 
700 0 1 |a Varró András  |e aut 
700 0 1 |a Farkas András  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/16883/1/2019_applicationOfVentricular_JPP.pdf  |z Dokumentum-elérés